The problem with that is it doesnt account for the fact that Sonny didnt become CEO based solely on his own merit but in large part due to his ties to Zimmer. Also the idea of him fleecing shareholders is incorrect. If the goal was, from the moment the 2013 IPO paperwork was filed, to go private again, Sonnys goal upon taking over Sintx would not be to "fleece" individuals but utilize public markets to raise funds to fund R&D. Its the hfudges that would be fleecing shareholders as they have to move their shares. That said, if the goal was to go private from the onset (before Sonny was even CEO), then he would want to see Sintx valuation stay low. If going private is the goal id keep an eye out for an acquisition offer from NP Aerospace. An alternative to that is a reverse merger so NP could go public.
Sonny is doing things by himself? CTL handles spine sales, NP Aerospace would handle armor sales, Zimmer Biomet would handle at least Hip & Knee sales. They supply aerospace components to unspecified aerospace companies. The only product he attempted to commercialize as an OEM and failed to, is the masks. That said, masks are free to commercialize with another company. Not a stretch to imagine that Zimmer Biomet could sell masks. I mean the company is looking to diversify its revenue sources.
Silicon Nitride, a Close to Ideal Ceramic Material for Medical Application
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
Extra information on the status of a Si3n4 based hip implant:
Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics, particularly in the manufacture of acetabular cups, due to their excellent biocompatibility, osteointegration, and tribological and mechanical properties, but all three materials need more study. However, silicon nitride is the nearest to commercialization, through businesses such as Amedica Corp. and SyntX Technologies